Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$405M |
| 2 |
Gilead Sciences
GILD
|
+$314M |
| 3 |
Union Pacific
UNP
|
+$229M |
| 4 |
Intel
INTC
|
+$224M |
| 5 |
Meta Platforms (Facebook)
META
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$342M |
| 2 |
SWY
SAFEWAY INC
SWY
|
+$210M |
| 3 |
TSMC
TSM
|
+$174M |
| 4 |
GSK
GSK
|
+$156M |
| 5 |
Johnson & Johnson
JNJ
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.05% |
| 2 | Technology | 11.94% |
| 3 | Consumer Discretionary | 11.2% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Staples | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Gaia
GAIA
$46.8M
| $1.18M | ﹤0.01% |
161,467
+44,667
| +38% | +$316K |
|
|
DVCR
2227
DELISTED
Diversicare Healthcare Services Inc
DVCR
| $1.18M | ﹤0.01% |
84,900
+4,200
| +5% | +$44.6K |
|
2228
Paylocity
PCTY
$7.38B
| $1.17M | ﹤0.01% |
+41,000
| New | +$1.13M |
|
2229
Artisan Partners
APAM
$2.79B
| $1.17M | ﹤0.01% |
25,800
-213,700
| -89% | -$10.1M |
|
2230
WPP
WPP
$4.36B
| $1.17M | ﹤0.01% |
10,300
-32,629
| -76% | -$3.66M |
|
2231
Franklin Covey
FC
$242M
| $1.16M | ﹤0.01% |
60,400
-7,329
| -11% | -$132K |
|
|
JNP
2232
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $1.16M | ﹤0.01% |
186,360
+75,354
| +68% | +$466K |
|
|
ARGO
2233
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.15M | ﹤0.01% |
29,098
+14,070
| +94% | +$547K |
|
|
RIOM
2234
DELISTED
RIO ALTO MNG LTD NEW COM SHS (CANADA)
RIOM
| $1.15M | ﹤0.01% |
466,300
+84,300
| +22% | +$234K |
|
2235
Sportsman's Warehouse
SPWH
$44.5M
| $1.15M | ﹤0.01% |
144,000
+131,439
| +1,046% | +$969K |
|
|
MBVT
2236
DELISTED
Merchants Bancshares Inc
MBVT
| $1.15M | ﹤0.01% |
39,300
-1,300
| -3% | -$37.2K |
|
2237
NACCO Industries
NC
$357M
| $1.14M | ﹤0.01% |
94,263
+57,496
| +156% | +$736K |
|
2238
NeoGenomics
NEO
$1.96B
| $1.14M | ﹤0.01% |
244,400
+107,700
| +79% | +$468K |
|
|
NPD
2239
DELISTED
CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM
NPD
| $1.14M | ﹤0.01% |
651,500
+12,078
| +2% | +$19K |
|
|
RLH
2240
DELISTED
Red Lions Hotel Corporation
RLH
| $1.14M | ﹤0.01% |
170,700
+73,800
| +76% | +$483K |
|
|
CERN
2241
DELISTED
Cerner Corp
CERN
| $1.14M | ﹤0.01% |
+15,500
| New | +$1.07M |
|
|
BNFT
2242
DELISTED
Benefitfocus, Inc.
BNFT
| $1.14M | ﹤0.01% |
+30,857
| New | +$922K |
|
2243
Cumberland Pharmaceuticals
CPIX
$100M
| $1.13M | ﹤0.01% |
170,188
+49,288
| +41% | +$308K |
|
2244
Casella Waste Systems
CWST
$5.71B
| $1.13M | ﹤0.01% |
205,100
+118,800
| +138% | +$514K |
|
|
FCRE
2245
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
| $1.13M | ﹤0.01% |
112,200
+39,360
| +54% | +$336K |
|
|
GHDX
2246
DELISTED
Genomic Health, Inc.
GHDX
| $1.13M | ﹤0.01% |
36,900
+24,700
| +202% | +$785K |
|
2247
Lakeland Financial Corp
LKFN
$1.56B
| $1.12M | ﹤0.01% |
41,550
+20,850
| +101% | +$557K |
|
2248
Silicom
SILC
$229M
| $1.12M | ﹤0.01% |
27,200
+21,200
| +353% | +$888K |
|
2249
Tandem Diabetes Care
TNDM
$1.34B
| $1.12M | ﹤0.01% |
+8,910
| New | +$1.16M |
|
2250
Citizens & Northern Corp
CZNC
$456M
| $1.12M | ﹤0.01% |
55,617
+41,717
| +300% | +$825K |
|
Similar funds
Renaissance Technologies's Q1 2015 Portfolio in Review
As of Q1 2015, Renaissance Technologies held 3,575 positions worth $47B, up 13% from $41.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
Renaissance Technologies deployed $4.23B of net new capital in Q1 2015, opening 633 new positions and adding to 1,637 existing holdings. Its largest new stake was Amazon: 23,057,100 shares worth $429M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was McDonald's, an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2015 buy was Amazon: 23,057,100 shares worth $429M.
- Renaissance Technologies added most to Gilead Sciences in Q1 2015, an estimated $314M increase.
- Renaissance Technologies's biggest Q1 2015 reduction was McDonald's, cutting an estimated $342M.
- Renaissance Technologies fully exited SAFEWAY INC in Q1 2015, selling an estimated $210M.
- Renaissance Technologies's ten largest holdings make up 9.9% of its $47B portfolio in Q1 2015.
- Renaissance Technologies opened 633 new positions and closed 438 in Q1 2015.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $47B.
Based on Renaissance Technologies's 13F filing for Q1 2015, filed 13 May 2015.